Pacific Biosciences of California Inc (PACB)
1.475
-0.08
(-5.45%)
USD |
NASDAQ |
Apr 23, 15:25
Pacific Biosciences of California Profit Margin (Quarterly): -140.5% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -140.5% |
| September 30, 2023 | -120.1% |
| June 30, 2023 | -146.8% |
| March 31, 2023 | -226.3% |
| December 31, 2022 | -308.5% |
| September 30, 2022 | -238.2% |
| June 30, 2022 | -201.3% |
| March 31, 2022 | -245.7% |
| December 31, 2021 | -192.5% |
| September 30, 2021 | 47.42% |
| June 30, 2021 | -133.9% |
| March 31, 2021 | -301.5% |
| December 31, 2020 | |
| September 30, 2020 | -124.2% |
| June 30, 2020 | -135.2% |
| March 31, 2020 | 8.09% |
| December 31, 2019 | -0.33% |
| September 30, 2019 | -132.9% |
| June 30, 2019 | -99.90% |
| March 31, 2019 | -184.6% |
| December 31, 2018 | -157.7% |
| September 30, 2018 | -137.9% |
| June 30, 2018 | -104.5% |
| March 31, 2018 | -124.9% |
| December 31, 2017 | -83.26% |
| Date | Value |
|---|---|
| September 30, 2017 | -93.53% |
| June 30, 2017 | -127.2% |
| March 31, 2017 | -95.79% |
| December 31, 2016 | -73.98% |
| September 30, 2016 | -69.65% |
| June 30, 2016 | -89.16% |
| March 31, 2016 | -101.2% |
| December 31, 2015 | -3.88% |
| September 30, 2015 | 13.08% |
| June 30, 2015 | -47.86% |
| March 31, 2015 | -114.3% |
| December 31, 2014 | -112.3% |
| September 30, 2014 | -44.43% |
| June 30, 2014 | -167.5% |
| March 31, 2014 | -162.2% |
| December 31, 2013 | -188.7% |
| September 30, 2013 | -276.1% |
| June 30, 2013 | -338.5% |
| March 31, 2013 | -378.3% |
| December 31, 2012 | -368.6% |
| September 30, 2012 | -818.8% |
| June 30, 2012 | -308.4% |
| March 31, 2012 | -274.8% |
| December 31, 2011 | -183.4% |
| September 30, 2011 | -278.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-308.5%
Minimum
Dec 2022
47.42%
Maximum
Sep 2021
-149.6%
Average
-137.9%
Median
Profit Margin (Quarterly) Benchmarks
| Cerus Corp | -2.84% |
| Axogen Inc | -9.07% |
| AVITA Medical Inc | -49.77% |
| BioSig Technologies Inc | -50.41K% |
| Intellia Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.62% |
| Return on Assets | -16.75% |
| Return on Invested Capital | -19.58% |
| Gross Profit Margin (Quarterly) | 16.40% |
| Operating Margin (Quarterly) | -148.0% |
| Return on Net Operating Assets | -28.73% |